Company page

Pds Biotechnology Corporation

PDS Biotechnology Corporation, trading under the ticker PDSB, is a public company based in the United States with a market capitalization of approximately $56.9 million. The company focuses on developing innovative therapies for cancer treatment. PDSB is committed to advancing its pipeline of immunotherapy products to improve patient outcomes.